Long-term cost-effectiveness of Clopidogrel® in patients with acute coronary syndrome without ST-segment elevation in Germany

被引:1
|
作者
Brüggenjürgen, B
Ehlken, B
机构
[1] Alpha Care GmbH, Celle, Germany
[2] MERG, Munich, Germany
关键词
D O I
10.1016/S1098-3015(10)65787-7
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:686 / 686
页数:1
相关论文
共 50 条
  • [41] Benefit of Clopidogrel in patients with acute coronary syndromes without ST-segment elevation (ACS) in various risk groups
    Budaj, AJ
    Yusuf, S
    Mehta, SR
    Fox, KAA
    Tognoni, G
    Zhao, F
    Chrolavicius, S
    Hunt, D
    Keltai, M
    Franzosi, MG
    CIRCULATION, 2002, 106 (19) : 455 - 455
  • [42] Evaluation of Angiographic Collateral Circulation in Patients with Acute Coronary Syndrome Without St-Segment Elevation
    Lazoglu, Z.
    Topcu, S.
    Askin, L.
    Kalkan, K.
    Aksu, U.
    Uslu, A.
    Senocak, H.
    Aksakal, E.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (07): : S127 - S127
  • [43] Short- and long-term cost-effectiveness analysis of adding clopidogrel to standard therapy in acute coronary syndrome patients in Spain
    Badia, X
    Bueno, H
    Juanatey, JRG
    Valentín, V
    Rubio, M
    REVISTA ESPANOLA DE CARDIOLOGIA, 2005, 58 (12): : 1385 - 1395
  • [44] Cost-effectiveness of clopidogrel versus ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome
    Van den Broek, W. W. A.
    Van Paassen, J. G.
    Gimbel, M. E.
    Deneer, V. H. M.
    Ten Berg, J. M.
    Vreman, R. A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2846 - 2846
  • [45] Long-term clinical outcomes in patients with non-ST-segment Elevation Acute Coronary Syndrome and ST-segment elevation myocardial infarction with thrombolysis in myocardial infarction 0 flow
    Aarts, Bart R. A.
    Groenland, Frederik T. W.
    Elscot, Jaimy
    Neleman, Tara
    Wilschut, Jeroen M.
    Kardys, Isabella
    Nuis, Rutger-Jan
    Diletti, Roberto
    Daemen, Joost
    Mieghem, Nicolas M. Van
    Dekker, Wijnand K. den
    IJC HEART & VASCULATURE, 2023, 48
  • [46] Management of Acute Coronary Syndromes in Patients Without Persistent ST-Segment Elevation
    Anchan, Rajeev
    Cifu, Adam S.
    Paul, Jonathan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (15): : 1556 - 1557
  • [47] CHARACTERIZATION OF INDIVIDUALIZED PROTEOMIC PROFILES IN ST-SEGMENT ELEVATION AND NON ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME
    Laborde, C. M.
    Mourino, L.
    Alonso-Orgaz, S.
    Moreu, J.
    Padial, L. R.
    Vivanco, F.
    Gil-Dones, F.
    Barderas, M. G.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S318 - S318
  • [48] Antiplatelet therapy resistance in patients with acute coronary syndrome with ST-segment elevation
    Ainetdinova, D. H.
    Udovichenko, A. E.
    Sulimov, V. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2008, 4 (02) : 23 - 29
  • [49] Pneumopericardium mimicking ST-segment elevation acute coronary syndrome
    Fernandez Asensio, Rodrigo
    Pascual Calleja, Isaac
    Moris de la Tassa, Cesar
    Colunga Blanco, Santiago
    EUROPEAN HEART JOURNAL, 2022, 43 (15) : 1516 - 1516
  • [50] Diffuse ST-segment elevation beyond acute coronary syndrome
    Zhu, Hai
    Wang, Aqian
    Cao, Yunshan
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2022, 7 (01)